Change of mucus rheology in patients with Cystic Fibrosis, COPD and Asthma

J. PATARIN (Grenoble, France), E. Ghiringhelli (Grenoble, France), C. Cracowski (Grenoble, France), B. Camara (Grenoble, France), S. Quetant (Grenoble, France), C. Bosc (Grenoble, France), C. Pison (Grenoble, France), J. Cracowski (Grenoble, France)

Source: International Congress 2018 – Biomarkers and lung function in airway disease
Session: Biomarkers and lung function in airway disease
Session type: Poster Discussion
Number: 5051
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. PATARIN (Grenoble, France), E. Ghiringhelli (Grenoble, France), C. Cracowski (Grenoble, France), B. Camara (Grenoble, France), S. Quetant (Grenoble, France), C. Bosc (Grenoble, France), C. Pison (Grenoble, France), J. Cracowski (Grenoble, France). Change of mucus rheology in patients with Cystic Fibrosis, COPD and Asthma. 5051

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Does physiotherapy affect Lung Clearance Index in Cystic Fibrosis patients ?
Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research
Year: 2018

Is Pulmonary Medication Adherence affected by disease severity among adult patients with Cystic Fibrosis?
Source: Virtual Congress 2020 – Clinical monitoring and new therapies for cystic fibrosis
Year: 2020


Sputum processing methods in airway disease: Which is best?
Source: International Congress 2014 – Airway biomarkers
Year: 2014

Two-compartment model of gas mixing in patients with asthma and cystic fibrosis
Source: Annual Congress 2013 –Clinical respiratory physiology in different diseases
Year: 2013

Assessment of aerobic fitness in cystic fibrosis and asthmatic children
Source: International Congress 2014 – Respiratory function at rest and during exercise
Year: 2014


Lung clearance index predicts pulmonary exacerbations in cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014

Induced sputum and bronchial hyperresponsiveness in COPD patients
Source: International Congress 2014 – Airway biomarkers
Year: 2014


Lung Clearance Index (LCI) and FEV1 on the evaluation of the effect of tobramycin solution for inhalation (TIS) among patients with cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014


Lung deposition of inhaled colistimethate sodium in cystic fibrosis patients
Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects
Year: 2014

Small airways obstruction and asthma exacerbations
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014

Comparison of the Cystic Fibrosis Questionnaire with the St George‘s Respiratory Questionnaire in adult patients with cystic fibrosis
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new aspects of risk factors, treatments and diagnosis
Year: 2012

Severity of airway obstruction in overweight/obese patients with chronic obstructive pulmonary disease(COPD)
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014


LATE-BREAKING ABSTRACT: Efficacy of Pirfenidone for Idiopathic Pulmonary Fibrosis (IPF): an Italian real life study
Source: International Congress 2014 – IPF and surroundings
Year: 2014


Biomarkers for sputum eosinophilia in mild-moderate and severe adult-onset asthma patients
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014


Exercise may improve airway clearance and alleviate hyperinflation in children with Cystic Fibrosis
Source: International Congress 2018 – Improvements in the assessment of paediatric physiology
Year: 2018


Adaptation of prevotella during acute infectious pulmonary exacerbation
Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology
Year: 2014

Sensitivity to Mannitol and Airway Obstruction in Patients with Asthma, COPD and Healthy smokers
Source: Virtual Congress 2020 – Advances in lung function practice
Year: 2020


Comparing Respiratory Pathogen in patients with non-Cystic Fibrosis bronchiectasis during clinically stable and exacerbation
Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease
Year: 2018




Small airways obstruction and exhaled particles in asthma
Source: International Congress 2014 – Biomarkers of asthma control
Year: 2014


Annual change of LCI among patients with cystic fibrosis
Source: International Congress 2016 – Cystic fibrosis: monitoring and management
Year: 2016